Chemical Formula: C11H13N3S

ID11614

C11H13N3S (219.0830138)

ID11614 is a metabolite of lurasidone. Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 28, 2010 after a review that found that two of the four Phase III clinical trials supported efficacy, while one showed only marginal efficacy and one was not interpretable because of high drop-out rates. (Wikipedia)

7-(1-piperazinyl-thieno[2,3-c]pyridine, monohydrochloride

C11H13N3S (219.0830138)

Thiourea,N-(2-cyanoethyl)-N-(phenylmethyl)-

C11H13N3S (219.0830138)

5-BENZYL-4-ETHYL-4H-1,2,4-TRIAZOLE-3-THIOL

C11H13N3S (219.0830138)

3-(1-Piperazinyl)-1,2-benzisothiazole

C11H13N3S (219.0830138)

2-piperazin-1-yl-benzothiazole

C11H13N3S (219.0830138)

4-piperazin-1-ylthieno[3,2-c]pyridine

C11H13N3S (219.0830138)

ART-CHEM-BB B018025

C11H13N3S (219.0830138)

2-(1H-INDOL-3-YL)-ETHYL]-THIOUREA

C11H13N3S (219.0830138)

5-(4-ISOPROPYLPHENYL)-1,3,4-THIADIAZOL-2-AMINE

C11H13N3S (219.0830138)

Thieno[2,3-c]pyridine, 7-(1-piperazinyl)-

C11H13N3S (219.0830138)